Literature DB >> 21510936

Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells.

Mariko Taga1, François Mouton-Liger, Claire Paquet, Jacques Hugon.   

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) pathway including p70(S6K) (the 70-kDa p70 S6 kinase) and S6, controls protein synthesis, has anti-apoptotic functions and can phosphorylate tau protein. mTORC1 is triggered by nutrients such as phosphatidic acid (PA). Previous experimental studies have shown that oxidative stress may down-regulate this pathway leading to neuronal death. Our results showed that in human neuroblastoma cells, PA exposure can reduce H(2)O(2)-induced apoptosis and can increase tau protein phosphorylation on Ser214 via p70(S6K) activation. These findings reveal that PA, via the mTOR kinase, can trigger tau phosphorylation on a site known to reduce paired helical filament (PHF) formation.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21510936     DOI: 10.1016/j.febslet.2011.04.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; George Perry; Jesús Avila; Vega García-Escudero
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

2.  Rapamycin, Autophagy, and Alzheimer's Disease.

Authors:  Zhiyou Cai; Liang-Jun Yan
Journal:  J Biochem Pharmacol Res       Date:  2013-06

3.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

5.  New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.

Authors:  Xinhui Sun; Yiping Su; Yuanlin He; Jing Zhang; Wenwen Liu; Huilin Zhang; Zheng Hou; Jiayin Liu; Jing Li
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone.

Authors:  Rodolfo Pinto-Almazan; Julia J Segura-Uribe; Marvin A Soriano-Ursúa; Eunice D Farfán-García; Juan M Gallardo; Christian Guerra-Araiza
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

7.  Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice.

Authors:  Inbal Lahiani-Cohen; Olga Touloumi; Roza Lagoudaki; Nikolaos Grigoriadis; Hanna Rosenmann
Journal:  Front Cell Dev Biol       Date:  2020-01-14

Review 8.  Deconstructing mitochondrial dysfunction in Alzheimer disease.

Authors:  Vega García-Escudero; Patricia Martín-Maestro; George Perry; Jesús Avila
Journal:  Oxid Med Cell Longev       Date:  2013-06-11       Impact factor: 6.543

Review 9.  Activation of mTOR: a culprit of Alzheimer's disease?

Authors:  Zhiyou Cai; Guanghui Chen; Wenbo He; Ming Xiao; Liang-Jun Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-09       Impact factor: 2.570

10.  A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.

Authors:  Soo Youn Lee; Min-Young Song; Dain Kim; Chaewon Park; Da Kyeong Park; Dong Geun Kim; Jong Shin Yoo; Young Hye Kim
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.